BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 31923538)

  • 1. Transferrin-binding peptide functionalized polymersomes mediate targeted doxorubicin delivery to colorectal cancer in vivo.
    Wei Y; Gu X; Sun Y; Meng F; Storm G; Zhong Z
    J Control Release; 2020 Mar; 319():407-415. PubMed ID: 31923538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-toxicity transferrin-guided polymersomal doxorubicin for potent chemotherapy of orthotopic hepatocellular carcinoma in vivo.
    Wei Y; Gu X; Cheng L; Meng F; Storm G; Zhong Z
    Acta Biomater; 2019 Jul; 92():196-204. PubMed ID: 31102765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptide-conjugated PAMAM for targeted doxorubicin delivery to transferrin receptor overexpressed tumors.
    Han L; Huang R; Liu S; Huang S; Jiang C
    Mol Pharm; 2010 Dec; 7(6):2156-65. PubMed ID: 20857964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibiting Multidrug Resistance with Transferrin-Targeted Polymersomes through Optimization of Ligand Density.
    Yi SL; Li ZL; Gong YC; Xiong XY
    Langmuir; 2023 Nov; 39(45):15920-15931. PubMed ID: 37922445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ATN-161 Peptide Functionalized Reversibly Cross-Linked Polymersomes Mediate Targeted Doxorubicin Delivery into Melanoma-Bearing C57BL/6 Mice.
    Zhang N; Xia Y; Zou Y; Yang W; Zhang J; Zhong Z; Meng F
    Mol Pharm; 2017 Aug; 14(8):2538-2547. PubMed ID: 28005375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted delivery of doxorubicin using stealth liposomes modified with transferrin.
    Li X; Ding L; Xu Y; Wang Y; Ping Q
    Int J Pharm; 2009 May; 373(1-2):116-23. PubMed ID: 19429296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transferrin and octaarginine modified dual-functional liposomes with improved cancer cell targeting and enhanced intracellular delivery for the treatment of ovarian cancer.
    Deshpande P; Jhaveri A; Pattni B; Biswas S; Torchilin V
    Drug Deliv; 2018 Nov; 25(1):517-532. PubMed ID: 29433357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced intracellular delivery and chemotherapy for glioma rats by transferrin-conjugated biodegradable polymersomes loaded with doxorubicin.
    Pang Z; Gao H; Yu Y; Guo L; Chen J; Pan S; Ren J; Wen Z; Jiang X
    Bioconjug Chem; 2011 Jun; 22(6):1171-80. PubMed ID: 21528923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bacterial magnetosomes loaded with doxorubicin and transferrin improve targeted therapy of hepatocellular carcinoma.
    Wang J; Geng Y; Zhang Y; Wang X; Liu J; Basit A; Miao T; Liu W; Jiang W
    Nanotheranostics; 2019; 3(3):284-298. PubMed ID: 31423412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transferrin-Copper Nanocluster-Doxorubicin Nanoparticles as Targeted Theranostic Cancer Nanodrug.
    Goswami U; Dutta A; Raza A; Kandimalla R; Kalita S; Ghosh SS; Chattopadhyay A
    ACS Appl Mater Interfaces; 2018 Jan; 10(4):3282-3294. PubMed ID: 29278317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folate-targeted polymersomes loaded with both paclitaxel and doxorubicin for the combination chemotherapy of hepatocellular carcinoma.
    Zhu D; Wu S; Hu C; Chen Z; Wang H; Fan F; Qin Y; Wang C; Sun H; Leng X; Kong D; Zhang L
    Acta Biomater; 2017 Aug; 58():399-412. PubMed ID: 28627436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EGFR-targeted multifunctional polymersomal doxorubicin induces selective and potent suppression of orthotopic human liver cancer in vivo.
    Fang Y; Yang W; Cheng L; Meng F; Zhang J; Zhong Z
    Acta Biomater; 2017 Dec; 64():323-333. PubMed ID: 29030307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A stabilized retro-inverso peptide ligand of transferrin receptor for enhanced liposome-based hepatocellular carcinoma-targeted drug delivery.
    Tang J; Wang Q; Yu Q; Qiu Y; Mei L; Wan D; Wang X; Li M; He Q
    Acta Biomater; 2019 Jan; 83():379-389. PubMed ID: 30395963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. cRGD-decorated biodegradable polytyrosine nanoparticles for robust encapsulation and targeted delivery of doxorubicin to colorectal cancer in vivo.
    Gu X; Wei Y; Fan Q; Sun H; Cheng R; Zhong Z; Deng C
    J Control Release; 2019 May; 301():110-118. PubMed ID: 30898610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transferrin/folate dual-targeting Pluronic F127/poly(lactic acid) polymersomes for effective anticancer drug delivery.
    Wang QX; Chen X; Li ZL; Gong YC; Xiong XY
    J Biomater Sci Polym Ed; 2022 Jun; 33(9):1140-1156. PubMed ID: 35179085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-targeted and pH-controlled delivery of doxorubicin using gold nanorods for lung cancer therapy.
    Amreddy N; Muralidharan R; Babu A; Mehta M; Johnson EV; Zhao YD; Munshi A; Ramesh R
    Int J Nanomedicine; 2015; 10():6773-88. PubMed ID: 26604751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel transferrin modified and doxorubicin loaded Pluronic 85/lipid-polymeric nanoparticles for the treatment of leukemia: In vitro and in vivo therapeutic effect evaluation.
    Zhu B; Zhang H; Yu L
    Biomed Pharmacother; 2017 Feb; 86():547-554. PubMed ID: 28024291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted Delivery of Doxorubicin Using Transferrin-Conjugated Carbon Dots for Cancer Therapy.
    Li L; Zhang Q; Li J; Tian Y; Kang Y; Ren G; Liu W; Wang H; Wang B; Yan L; Guo L; Diao H
    ACS Appl Bio Mater; 2021 Sep; 4(9):7280-7289. PubMed ID: 35006957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective Cell Penetrating Peptide-Functionalized Polymersomes Mediate Efficient and Targeted Delivery of Methotrexate Disodium to Human Lung Cancer In Vivo.
    Yang W; Xia Y; Fang Y; Meng F; Zhang J; Cheng R; Deng C; Zhong Z
    Adv Healthc Mater; 2018 Apr; 7(7):e1701135. PubMed ID: 29280317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective transferrin coating as a facile strategy to fabricate BBB-permeable and targeted vesicles for potent RNAi therapy of brain metastatic breast cancer in vivo.
    Wei Y; Sun Y; Wei J; Qiu X; Meng F; Storm G; Zhong Z
    J Control Release; 2021 Sep; 337():521-529. PubMed ID: 34352315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.